To include your compound in the COVID-19 Resource Center, submit it here.

Advicenne reports Phase III data for renal tubular acidosis candidate

In September, Advicenne Pharma S.A. (Nimes, France) reported data from a Phase III trial showing that among

Read the full 179 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE